Aytu BioPharma, Inc. (LON:0A8M)
2.200
+0.520 (30.95%)
At close: May 16, 2025
Aytu BioPharma Employees
Aytu BioPharma had 102 employees as of June 30, 2024. The number of employees decreased by 48 or -32.00% compared to the previous year.
Employees
102
Change (1Y)
-48
Growth (1Y)
-32.00%
Revenue / Employee
619.64K GBP
Profits / Employee
12.44K GBP
Market Cap
15.24M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 102 | -48 | -32.00% |
Jun 30, 2023 | 150 | -14 | -8.54% |
Jun 30, 2022 | 164 | -11 | -6.29% |
Jun 30, 2021 | 175 | 100 | 133.33% |
Jun 30, 2020 | 75 | 14 | 22.95% |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
HSBC Holdings | 211,304 |
Shell | 96,000 |
Unilever | 115,964 |
Rolls-Royce Holdings | 42,400 |
British American Tobacco p.l.c. | 48,989 |
Rio Tinto Group | 60,000 |
BP p.l.c. | 100,500 |